4.5 Article

Estrogen receptor alpha and beta in health and disease

Journal

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.beem.2015.04.008

Keywords

estrogen receptors; cancer; metabolic disease

Funding

  1. Swedish Cancer Fund
  2. Robert A. Welch Foundation [E-0004]

Ask authors/readers for more resources

Estrogen receptors alpha (ER alpha) and beta (ER beta) are transcription factors that are involved in the regulation of many complex physiological processes in humans. Abnormal ER signaling leads to development of a variety of diseases, such as cancer, metabolic and cardiovascular disease, neurodegeneration, inflammation, and osteoporosis. This review provides an overview and update on ER alpha and ER beta in health and disease with focus on their role in cancer and metabolic disease and in the context of recent years' success in providing genome wide data on ER function. Furthermore, potential clinical applications and challenges are also discussed. (C) 2015 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available